Stock CIPHER PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Cipher Pharmaceuticals Inc Nasdaq

Equities

CA17253X1050

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50
MT
Cipher Pharmaceuticals Upgraded to Buy at Stifel GMP; Price Target Raised to C$8.00
MT
Cipher Pharmaceuticals Upgraded to Speculative Buy at Stifel GMP; Price Target Raised to C$4.75
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CPH Stock
  4. Stock
  5. News Cipher Pharmaceuticals Inc
  6. Analyst Reco.